Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share

Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.17), $1.01 better than the analyst estimate of ($2.18).

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins